CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance environmental safety by developing frameworks for assessing the risks of active pharmaceutical ingredients (APIs). It focuses on improving testing methods and prioritizing legacy pharmaceuticals for environmental monitoring based on toxicological and pharmacological data.
Active pharmaceutical ingredients (APIs) can be released to the natural environment during the manufacturing process, following use by patients or when unused medicines are disposed of.
As APIs are biologically active compounds concerns have been raised about the potential effects of APIs in the environment on human and environmental health.
Over the past 15 years, a substantial amount of work has been done to determine the occurrence, fate, effects, and resulting risks of APIs in the environmen…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, York North Yorkshire
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
HELMHOLTZ-ZENTRUM FUR UMWELTFORSCHUNG GMBH - UFZ
Germany, Leipzig
Type: Research institute
Activity type: Research Organisations
SME: No
Germany, Florsheim
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
